Your browser doesn't support javascript.
loading
Sleep predicts the response to rTMS and CBT in patients with OCD: an open label effectiveness study.
Gajadien, Priya T; Postma, Tjardo S; van Oostrom, Iris; Scheepstra, Karel W F; van Dijk, Hanneke; Sack, Alexander T; van den Heuvel, Odile A; Arns, Martijn.
Afiliação
  • Gajadien PT; Universiteit van Amsterdam, the Netherlands.
  • Postma TS; Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, the Netherlands.
  • van Oostrom I; Department of Psychiatry and Department of Anatomy & Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience (Compulsivity, Impulsivity and Attention), Amsterdam, The Netherlands.
  • Scheepstra KWF; neurocare clinics, Nijmegen, the Netherlands.
  • van Dijk H; Amsterdam UMC, University of Amsterdam, Adult Psychiatry, Amsterdam Neuroscience, Meibergdreef 9, Amsterdam, Netherlands.
  • Sack AT; Neuroimmunology research group, Netherlands Institute for Neuroscience, Meibergdreef 47, 1105 BA, Amsterdam, the Netherlands.
  • van den Heuvel OA; Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, the Netherlands.
  • Arns M; Faculty of Psychology and Neuroscience, Maastricht University, the Netherlands.
Int J Clin Health Psychol ; 23(2): 100353, 2023.
Article em En | MEDLINE | ID: mdl-36415607
ABSTRACT

Background:

Although many OCD patients benefit from repetitive transcranial magnetic stimulation (rTMS) as treatment, there is still a large group failing to achieve satisfactory response. Sleep problems have been considered transdiagnostic risk factors for psychiatric disorders, and prior work has shown comorbid sleep problems in OCD to be associated with non-response to rTMS in OCD. We therefore set out to investigate the utility of sleep problems in predicting response to rTMS in treatment resistant OCD.

Method:

A sample of 61 patients (treated with 1-Hz SMA or sequential 1-Hz SMA+DLPFC rTMS, combined with cognitive behavioral therapy) were included. Sleep disturbances were measured using the PSQI, HSDQ and actigraphy. Treatment response was defined as a decrease of at least 35% in symptom severity as measured with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).

Results:

32 of 61 patients (52.5%) responded to rTMS, and trajectories of response were similar for both rTMS protocols. Three PSQI items (Subjective Sleep Quality; Sleep Latency and Daytime Dysfunction) and the HSDQ-insomnia scale were found to predict TMS response. A discriminant model yielded a significant model, with an area under the curve of 0.813.

Conclusion:

Future replication of these predictors could aid in a more personalized treatment for OCD.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article